Role of Glycated High Mobility Group Box-1 in Gastric Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 May 2021
Historique:
received: 06 04 2021
revised: 06 05 2021
accepted: 11 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 11 6 2021
Statut: epublish

Résumé

Advanced glycation end products (AGEs) are produced in response to a high-glucose environment and oxidative stress and exacerbate various diseases.

Identifiants

pubmed: 34068442
pii: ijms22105185
doi: 10.3390/ijms22105185
pmc: PMC8153607
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Glycation End Products, Advanced 0
HMGB1 Protein 0
HMGB1 protein, human 0
Receptor for Advanced Glycation End Products 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : MEXT KAKENHI
ID : 19K16564
Organisme : MEXT KAKENHI
ID : 20K21659
Organisme : MEXT KAKENHI
ID : 20K19349
Organisme : Natural Science Foundation of Jiangsu Education Department Project
ID : 17KJB320010
Organisme : National Natural Science Foundation of China
ID : 81702723

Références

Biochemistry. 1996 Jun 18;35(24):8075-83
pubmed: 8672512
J Pathol. 2018 Jun;245(2):197-208
pubmed: 29533466
FASEB J. 2009 May;23(5):1510-20
pubmed: 19109409
Cardiovasc Pathol. 2008 May-Jun;17(3):129-38
pubmed: 18402807
Vasc Med. 1998;3(2):131-7
pubmed: 9796076
Diabetes Res. 1990 Apr;13(4):195-8
pubmed: 2134212
J Pathol. 2002 Feb;196(2):163-70
pubmed: 11793367
Int J Mol Sci. 2017 Jul 28;18(8):
pubmed: 28788052
Histochem Cell Biol. 2017 May;147(5):625-634
pubmed: 28012130
Clin Exp Metastasis. 2012 Dec;29(8):915-25
pubmed: 22552372
Trends Endocrinol Metab. 2000 Nov;11(9):368-75
pubmed: 11042467
Biochemistry. 2007 Feb 27;46(8):2111-7
pubmed: 17269659
Front Oncol. 2020 Sep 29;10:552283
pubmed: 33117687
Int J Mol Sci. 2020 Dec 08;21(24):
pubmed: 33302440
Oncol Rep. 2003 Mar-Apr;10(2):445-8
pubmed: 12579287
Pathobiology. 2010;77(4):210-7
pubmed: 20616616
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
J Cell Biochem. 2018 Aug;119(8):6943-6952
pubmed: 29737584
Int J Clin Pharmacol Res. 2003;23(4):129-34
pubmed: 15224502
Eur J Biochem. 2000 Jul;267(13):4088-97
pubmed: 10866811
Oncotarget. 2018 Nov 27;9(93):36561-36574
pubmed: 30564297
J Pharmacol Sci. 2019 Apr;139(4):266-274
pubmed: 30871870
Proc Natl Acad Sci U S A. 1982 Feb;79(4):1163-5
pubmed: 6951165
Expert Opin Ther Targets. 2011 Feb;15(2):183-93
pubmed: 21204727
Nature. 2000 May 18;405(6784):354-60
pubmed: 10830965
Science. 1994 Nov 4;266(5186):807-10
pubmed: 7973635
Int J Cancer. 2003 May 10;104(6):722-7
pubmed: 12640679
Cancer Sci. 2008 Sep;99(9):1806-12
pubmed: 18616526
Int J Biol Macromol. 2014 Aug;69:476-81
pubmed: 24933520
Matrix Biol. 2017 May;59:95-108
pubmed: 27616134
Cancer Prev Res (Phila). 2020 Jul;13(7):601-610
pubmed: 32169887
Clin Genitourin Cancer. 2015 Oct;13(5):e347-51
pubmed: 25972296
Int J Mol Sci. 2019 Dec 30;21(1):
pubmed: 31905926
Drug Des Devel Ther. 2019 Aug 12;13:2787-2798
pubmed: 31496655
Oncol Rep. 2003 Nov-Dec;10(6):1863-8
pubmed: 14534709
J Leukoc Biol. 2013 Jun;93(6):865-73
pubmed: 23446148
Gut. 2010 Mar;59(3):348-56
pubmed: 19828468
J Gastroenterol. 2012 Oct;47(10):1073-83
pubmed: 22467055
Oncotarget. 2020 Aug 04;11(31):2982-2994
pubmed: 32821344
Nucleic Acids Res. 2008 Mar;36(4):1209-19
pubmed: 18160415
Biochem J. 2003 Nov 15;376(Pt 1):109-21
pubmed: 12911334
PLoS One. 2011;6(8):e23132
pubmed: 21829704
Cancer Res. 2014 Jan 1;74(1):330-40
pubmed: 24197136
Pathol Int. 2000 Oct;50(10):767-77
pubmed: 11107048
Curr Med Chem. 2007;14(15):1653-71
pubmed: 17584071
Front Immunol. 2020 Jun 10;11:1189
pubmed: 32587593
Nucleic Acids Res. 1989 Feb 11;17(3):1197-214
pubmed: 2922262
Food Funct. 2016 Jan;7(1):46-57
pubmed: 26462729
J Biol Chem. 1966 May 25;241(10):2397-404
pubmed: 5911618
Diabetes. 1996 Jul;45 Suppl 3:S77-80
pubmed: 8674899

Auteurs

Shingo Kishi (S)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Yukiko Nishiguchi (Y)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Kanya Honoki (K)

Department of Orthopedics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

Shiori Mori (S)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Rina Fujiwara-Tani (R)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Takamitsu Sasaki (T)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Kiyomu Fujii (K)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Isao Kawahara (I)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Kei Goto (K)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Chie Nakashima (C)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Akira Kido (A)

Department of Orthopedics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

Yasuhito Tanaka (Y)

Department of Orthopedics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

Yi Luo (Y)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.
Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, China.

Hiroki Kuniyasu (H)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH